International
The Morning Science

What science found today

‹
 

Research

Dual-action bacterial cancer therapy shrinks aggressive breast tumors in mouse models

Medical Xpress ·

Dual-action bacterial cancer therapy shrinks aggressive breast tumors in mouse models

The Brief

  • A research team from the Republic of Korea reports a dual-action bacterial cancer therapy that shrank aggressive breast tumors in mouse models.
  • Certain bacteria naturally accumulate within tumors, so they are being explored as carriers for anticancer agents.
  • The approach targets tumors that resist immune attack, recur and spread, which the source describes as a major challenge in cancer treatment.

Why it matters

The results come from mouse models, so they show a possible approach but not yet an effect in humans. Readers following cancer drug delivery should watch for follow-up studies.

Who’s affected

  • cancer researchers
  • oncologists and breast cancer specialists
  • readers following drug delivery research

Tumors that resist immune attack, recur and spread pose a major challenge to cancer treatment. Because certain bacteria naturally accumulate within tumors, they serve as potential carriers for anticancer agents. Addressing this, a research team from the Republic of Korea—led by…

How do you feel about this?

0 Comments